Prenetics Global Limited fell 36.6% on Wednesday, November 18, 2026, on 1,576,038 shares, 6.5 times its average daily volume. Headlines around the move:
Prenetics Global Limited (PRE:NASDAQ) closed at $10.48 on November 19, 2026, up 1.26% on the day. The stock trades 61.5% below its 52-week high of $27.24 and 14.7% above its 52-week low of $9.13. Over the past year, it lost 19.6%. Prenetics Global Limited is part of the Health Care sector.
In 252 trading sessions since November 18, 2025, PRE closed higher on 123 days (49%). Its best day was March 6, 2026 (+18.12%) and its worst was November 18, 2026 (-36.62%). The stock moved 10% or more in a single session 18 times. It opened at least 5% above the previous day's high 1 time.
Prenetics Global Ltd is a diagnostic and genetic testing company. It focuses on bringing health closer to millions of people globally and decentralising healthcare by making the three pillars, namely, Prevention, Diagnostics and Personalized Care, comprehensive and accessible to anyone, anytime and anywhere. It has operations across nine locations, including the United Kingdom, Hong Kong, India, South Africa, and Southeast Asia. The company develops consumer genetic testing and early colorectal cancer screening; provides COVID-19 testing, rapid point of care and at-home diagnostic testing and medical genetic testing.
Find more stocks like PRE with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.